-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Eliem Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2020 to Q2 2024.
- Eliem Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $512K, a 34.1% decline year-over-year.
- Eliem Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $2.84M, a 80.6% decline year-over-year.
- Eliem Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $12.8M, a 83.2% increase from 2022.
- Eliem Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $6.99M, a 87.1% increase from 2021.
- Eliem Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $3.74M, a 429% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)